High value partner to move your projects to completion faster

Flamma is a privately held, family run, family owned life science company with experience that dates back to its beginning in 1950. As a fully integrated small molecule CDMO, the Flamma Group offers a unique opportunity to accelerate your small molecules to the pharmaceutical marketplace. With the ability to leverage FDA inspected cGMP Italian production facilities along with 100% owned Chinese facilities (and now a cGMP site in the USA), Flamma provides a stable, secure supply chain for Active Pharmaceutical Ingredients (APIs), New Chemical Entities (NCEs), Registered Starting Materials (RSMs) and Key Intermediates. Flamma was awarded the maximum number of available CDMO Leadership Awards* for 2018 marking the 3rd year in a row that it received such an honor. Flamma was recognized as a Top Performer in all 6 CDMO Core Award Categories: Expertise, Reliability, Capabilities, Quality, Service and Compatibility. Flamma was also recognized as a Top Performer in all 7 Specialty Award Categories for the 3rd straight years. Those specialty categories are: Accessible Senior Management, State-of-the-Art, Innovation, On-Time Delivery, Right the First Time, Strength of Science, and Reputation. There were 110 CDMOs evaluated on 23 performance metrics by pharma industry sourcing professionals. Of these 110 CDMOs, Flamma was the ONLY small molecule CDMO that was rated as a TOP PERFORMER in all core & specialty categories.

Flamma attends numerous industry events

Here’s you can find all our events and news. Don’t miss the chance to stay updated!

VIEW ALL

STAY UP TO DATE WITH OUR NEWSLETTER

01/14/2020

JP Morgan 2020

January 13-16, 2020 in San Francisco, CA, USA. The 38th annual J.P. Morgan Healthcare Conference (JP...

MORE

01/14/2020

JP Morgan 2020

January 13-16, 2020 in San Francisco, CA, USA.

The 38th annual J.P. Morgan Healthcare Conference (JPM 2020) will take place January 13-16, 2020 in San Francisco, CA, USA. It is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

JPM Healthcare Conference – History

What is today known as the annual J.P. Morgan Healthcare Conference began in 1983 and was hosted by Hambrecht & Quist (H&Q). H&Q was acquired by Chase in 2000 and a year later Chase was acquired by J.P. Morgan. At its infancy, the conference featured just 20 companies, had about 200 attendees and focused on the biotech industry.

Today, while it is still at the Westin St. Francis in San Francisco, the annual J.P. Morgan Healthcare Conference brings thousands of investors from around the world together. The hundreds of companies presenting run the gamut, from start-ups to those with more than $300 billion in market cap, and encompass the entire global healthcare landscape, including pharmaceutical firms, healthcare service providers, profit and not-for-profits, and medical device companies.

Request a meeting

03/24/2020

DCAT Week 2020

New York City from March 23-26, 2020 DCAT Week is the premier business development event for compani...

MORE

03/24/2020

DCAT Week 2020

New York City from March 23-26, 2020

DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It is organized and hosted by the Drug, Chemical & Associated Technologies Association (DCAT). Held annually in March, DCAT Week ensures that members have a forum for high-level strategic meetings with key decision makers, timely educational programs, and important networking opportunities.

 

Request a meeting

We are Flamma

The Flamma Group provides a variety of pharmaceutical services including cGMP manufacturing of APIs, RSMs, NCEs, process R&D, and many other activities. We also have a significant number of products that we provide to those who require materials that are of the highest of quality.

Flamma provides a dependable assessment of your technical package and provide competitive yet viable offers.

Flamma can be of assistance for early stage pre-clinical development as well as for large-scale commercial manufacturing and everything in between. 

 

Flamma is a proud member of the European Fine Chemical Group

 

 

Services

Flamma produces new APIs and NCEs as well as a wide-ranging list of generic APIs, including products like Melatonin (MelaPure), Minoxidil and many more. Our Active Ingredients include compounds like Asparagine. Our intermediates consist of numerous high-value amino acid derivatives including Moc-Valine, Cbz-L-Alanine and others too numerous to list here.

MORE

Custom Development

  • Process Development and Optimization
  • Custom synthesis
  • Scale-up capabilities
  • Analytical Validation and Development
  • and more…

Custom Manufacturing

  • Process Validation
  • Analytical Validation
  • Commercial Manufacturing from kilos to metric tons
  • Regulatory support including QA/QC
  • and more…

LOCATION

Discover our 6 locations from Italy to China, from France to the USA.

MORE